专题：Myasthenia Gravis and Thymoma

This cluster of papers focuses on the research related to myasthenia gravis, including its subgroups, clinical correlates, treatment strategies, and the role of autoantibodies. Additionally, it explores the classification and prognosis of thymic tumors, the efficacy of thymectomy, and the epidemiology of these conditions.
最新文献
The Etiology Analysis of Myasthenia Gravis with In-Hospital Mortality in the Neurocritical Care Unit

article Full Text OpenAlex

Comparison of Subxiphoid and Intercostal Uniportal Video‐Assisted Thoracoscopic Surgery for Early Thymoma, Lung Cancer, and Pneumothorax: A Retrospective Single‐Center Study

article Full Text OpenAlex

Efgartigimod versus standard of care in new-Onset AChR subtype generalized myasthenia gravis: A prospective cohort study

article Full Text OpenAlex

Real‐World Multinational Survey of Chronic Inflammatory Demyelinating Polyneuropathy: Disease Characteristics and Therapeutic Landscape

article Full Text OpenAlex

Let's Get It Off the Chest: What is the Optimal Adjuvant Approach for Stage IVa Thymoma With Pleural Metastases Only?

editorial Full Text OpenAlex

Pyridostigmine and IVIG-Induced Coronary Vasospasm in Myasthenia Gravis: A Rarely Reported Side Effect of Treatment of MG

article Full Text OpenAlex

Microscopic polyangiitis

reference-entry Full Text OpenAlex

Single‐cell atlas reveals heterogeneous response to FcRn blockade in anti‐AChR antibody‐positive generalised myasthenia gravis

article Full Text OpenAlex

A new variant in UNC50, which manifests phenotypically as congenital myasthenic syndrome, requires extensive clinical, electrophysiological, and biochemical investigations

article Full Text OpenAlex

Use of Corticosteroids in Myasthenia Gravis: Expert Opinion for Daily Management

article Full Text OpenAlex

近5年高被引文献
Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial

article Full Text OpenAlex 475 FWCI43.19

European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force—Second revision

article Full Text OpenAlex 366 FWCI38.25

European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force—Second revision

article Full Text OpenAlex 332 FWCI31.917

Myasthenia Gravis: Epidemiology, Pathophysiology and Clinical Manifestations

review Full Text OpenAlex 325 FWCI9.078

The 2021 WHO Classification of Tumors of the Thymus and Mediastinum: What Is New in Thymic Epithelial, Germ Cell, and Mesenchymal Tumors?

review Full Text OpenAlex 240 FWCI6.955

Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study

article Full Text OpenAlex 178 FWCI49.81

Epidemiology, diagnostics, and biomarkers of autoimmune neuromuscular junction disorders

review Full Text OpenAlex 176 FWCI8.343

Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study

article Full Text OpenAlex 161 FWCI44.971

Terminal Complement Inhibitor Ravulizumab in Generalized Myasthenia Gravis

article Full Text OpenAlex 159 FWCI24.496

Safety and clinical activity of autologous RNA chimeric antigen receptor T-cell therapy in myasthenia gravis (MG-001): a prospective, multicentre, open-label, non-randomised phase 1b/2a study

article Full Text OpenAlex 148 FWCI33.295